Israel: Stem Cells

(asked on 25th April 2016) - View Source

Question to the Foreign, Commonwealth & Development Office:

To ask Her Majesty’s Government what assessment they have made of the effectiveness of the stem cell research collaboration between British and Israeli scientists under the auspices of the Britain Israel Research and Academic Exchange Partnership.


This question was answered on 4th May 2016

The effectiveness of the Britain Israel Research and Academic Exchange Partnership (BIRAX) comes firstly from its robust selection process. All projects are assessed during the selection process for their quality of science and contribution to the scientific community by a selection panel of leading researchers in their field from the UK and Israel, and also by an anonymous peer review process, that includes leading researchers around the world. During their implementation, projects are monitored via yearly narrative and financial reporting, in addition to reporting on Researchfish. The British Council is planning a comprehensive evaluation exercise this year, which is the programme’s 5th year.

In addition, the programme is being co-funded by leading health research organisations such as British Heart Foundation, Juvenile Diabetes Research Foundation, Multiple Sclerosis Society and Parkinson's UK, who evaluate the projects before making their funding commitment and ensure their scientific excellence.

While the projects are too recent to be assessed for their impact on the Regenerative Medicine scientific field, so far a number of publications have emanated from the programme, including a ground-breaking article in Cell by Professor Yaqub Hanna in collaboration with Professor Azim Surani from The University of Cambridge. The article was assessed by the journal to be their number one paper last year. Articles by BIRAX grantees have also been published in Nature, Cell Biology, Frontiers in Immunology, Cancer Stem Cells and International Innovation.

The Programme is the only platform for bilateral cooperation between Israel and UK researchers in the field of regenerative medicine and stem cell research. Over 30 labs are involved in the projects, and hundreds of scientists are working on the Programme’s project. Over 1000 scientists took part in the bi-annual BIRAX conferences, with the recent conference which took place at the University of Oxford, this April being the largest.

Reticulating Splines